THE BENEFIT OF SINGLE INHALER TRIPLE THERAPY IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Journal Title: Pulmonologija ir alergologija - Year 2018, Vol 2, Issue 2

Abstract

Chronic obstructive pulmonary disease (COPD) is characterised by persistent obstruction of lung airflow, determinating respiratory symptoms, which increase while disease is progressing and exacerbations are reccuring. According to Global Initiative for Obstructive Lung Disease (GOLD), triple therapy with an inhaled glucocorticoid (iGK), a long-acting β2-agonist (LABA) and a long-acting muscarinic antagonist (LAMA), should be prescribed for patients who have clinically significant symptoms despite treatment with iGK/LABA or LAMA/LABA and who are at increased risk for moderate or severe exacerbations. Efficacy of triple therapy is demonstrated by FULFIL (Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease) and IMPACT (InforMing the PAthway of COPD Treatment) clinical trials findings. In fluticasone furoate / umeclidinium / vilanterol group a statistically significant reduction in the moderate and severe COPD exacerbations, as well as improvement of lung function and health-related quality of life were observed, comparing with groups of dual therapy. Meanwhile any differences in safety profile were detected. Such triple therapy in single inhaler is promising pathway for COPD treatment in selected patients.

Authors and Affiliations

Giedrė Gurevičienė

Keywords

Related Articles

LUNG CANCER IMMUNOTHERAPY

The immune system plays a crucial role in protecting the body against cancer by recognizing and destroying cells it perceives as foreign. Cancer immunity strategies aim to restore immunity sy...

LABORATORY DIAGNOSTICS FOR SYSTEMIC AUTOIMMUNE DISEASES WITH PULMONARY INVOLVEMENT

Most of the systemic autoimmune diseases are related to multiorgan involvement. As expected in such a disease, the entire pulmonary system is vulnerable to injury. In this article, we present systemic autoimmune diseases...

MECHANOBIOLOGY IN STRUCTURAL LUNG CELLS AND THE IMPORTANCE OF IT’S CHANGES IN ASTHMA

Mechanobiology is an emerging field of science at the interface of biology and engineering that focuses on how physical forces and changes in the mechanical properties of cells and tissues contribute to development, cell...

HYPERSENSITIVITY REACTIONS FROM ANTICOAGULIANTS

Anticoagulants, including heparins, coumarins, direct thrombin inhibitors (hirudins) are the most widely used drugs. Based on various mechanisms all of them can provoke immediate or delayed hypersensitivity reactions...

THE TREATMENT OF SEVERE ALLERGIC ASTHMA WITH OMALIZUMAB

Omalizumab is effective for the treatment of severe allergic asthma irrespective of pre-treatment blood eosinophil count. Omalizumab decreases the rate of exacerbation, the dose of systemic and inhaled gliucocorticoids,...

Download PDF file
  • EP ID EP502771
  • DOI -
  • Views 118
  • Downloads 0

How To Cite

Giedrė Gurevičienė (2018). THE BENEFIT OF SINGLE INHALER TRIPLE THERAPY IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Pulmonologija ir alergologija, 2(2), 175-179. https://europub.co.uk/articles/-A-502771